NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Courtβs...
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 PR Newswire SAN DIEGO, Nov. 14...
Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented at IDWeek...
Shelf utilization inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024 Aditxt, Inc...
Aditxt, Inc. (NASDAQ: ADTX) (βAditxtβ or the βCompanyβ), a social innovation platform dedicated to accelerating promising health innovations...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova...
Evofem Secures Investor Support for Proposed Merger through Voting Agreements PR Newswire SAN DIEGO, Nov. 6...
This firm’s treatment for a disfiguring skin infection has demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies, and...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.